|
HELSINKI, Jan. 4, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced a new near-term business target. In 2021 Nanoform targets "at least 12 new non-GMP1 (pre-clinical) customer projects and at least one new GMP... |
